
The US maternity platform ProgenyHealth has announced the appointment of Susan Torroella as the company’s new CEO.
Torroella was chosen for the role by Dr Ellen Stang, who founded the company and has served as CEO since its creation in 2003, and members of Progeny’s board of managers.
Dr Stang will now serve as executive chairwoman in a strategic advisory role, as well as focusing her time on building a new ProgenyHealth foundation.
Torroella, who most recently served as president and CEO of ArmadaHealth, has been widely recognised for her leadership, operational scalability and strong product marketing background.
“I began my career working on maternal and infant programs in the international public sector. To come full circle and now lead ProgenyHealth, a leading national tech-enabled women’s healthcare company in maternity and NICU care management, is thrilling,” said the new CEO.
“Over my career, I have focused largely on helping companies operationalise and ladder up to their next level of growth.
“With the value and impact ProgenyHealth is delivering, the company is on the cusp of a new phase of exponential growth. I look forward to furthering the mission that Dr Stang first envisioned over two decades ago.”
Torroella joins the company as Stang seeks to begin the next phase of her career, focusing on the development of a new non-profit foundation to support the unmet needs of women, infants and their families across the US.
“From ProgenyHealth’s earliest moments, I sought to create a company that would make healthcare less fragmented, more equitable, and one which would approach healthcare much more holistically,” Stang explained.
“It has been an absolute honour to serve as the founder and CEO of ProgenyHealth over the last 20 years.
“I have been privileged to work with our exceptional internal teams, as well as our many dedicated clients and their leadership teams, to advance maternal and infant health outcomes throughout the US.
“I am thrilled to have Susan now leading our team and look forward to supporting her as she guides ProgenyHealth through its next chapter of growth and impact.”
Arneek Multani, ProgenyHealth board member and managing partner of Sunstone Partners, said: “Susan’s significant experience scaling companies and building teams speaks for itself and we are so excited to have someone as talented as Susan joining the team.
“We look forward to supporting her success as she leads ProgenyHealth into 2023 and beyond.”
Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









